Supriya Lifescience · NSE: SUPRIYA · BSE: 543434
Q3 FY22 results · Oct–Dec 2021
Supriya Lifescience reported revenue from operations of ₹117.00 crore and net profit of ₹39.64 crore for Q3 FY22 (Oct–Dec 2021), on a standalone basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 117.00 | — | — | — | — |
| Other income | 5.44 | — | — | — | — |
| Total income | 122.44 | — | — | — | — |
| Profit before tax | 40.07 | — | — | — | — |
| Net profit for the period | 39.64 | — | — | — | — |
| EPS, basic (₹) | 4.93 | — | — | — | — |
| Net margin (%) | 33.9 | — | — |
Standalone
- Filed with BSE
- 22 Jan 2022, 14:12 IST
- Board meeting
- 21 Jan 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE